The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $25,072.00 firm fixed price purchase order contract to Becton, Dickinson And Company (BD) for BD reagents to support vaccine research. The contract does not have a set-aside designation and is scheduled for completion on February 24, 2023. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and...
This is a $10,787.50 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases, a component of the Department of Health and Human Services National Institutes of Health, to Becton, Dickinson And Company (BD), a manufacturer of medical devices, instruments, reagents, and related products. The contract is for the supply of BD antibodies and does not have a set-aside designation. BD is an experienced federal contractor, holding several...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded Becton, Dickinson And Company (BD), a manufacturer of medical devices and supplies, a firm fixed-price purchase order valued at $20,116.80 for high parameter custom conjugates. This award does not have a set-aside designation. The award has a completion date of August 15, 2024. BD is a prime contractor that has received numerous federal contract awards...
This federal contract award is for $110,508.75 and was issued by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Becton, Dickinson and Company (BD) for the supply of BD Biosciences Immunocytometry products. The contract is a firm fixed-price Purchase Order with a completion date of September 30, 2017. BD, a leading global medical technology company, manufactures and supplies a range of medical devices,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $260,967.29 firm fixed price purchase order to Becton, Dickinson and Company (BD) on June 15, 2020. The contract is for the BD FACSARIA FUSION SO LASER OPTION UPGRADE IN SUPPORT OF COVID-19. The contract is not set aside. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and clinical...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Becton, Dickinson & Co. (BD) for COVID-19 research antibodies and related supplies. The award ceiling is $88,595.50 and it has an ultimate completion date of August 5, 2022. This requirement was competed without a small business set-aside under FAR Simplified Acquisition Procedures, as a brand name restriction for...
This federal contract award was made by the National Institute of Child Health and Human Development, a civilian agency within the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD), a global medical technology company. The $50,144.40 firm fixed-price purchase order was awarded on March 13, 2020 with a completion date of March 12, 2021. It did not have a set-aside designation. BD Biosciences, a division of BD, provides instruments, reagents, and services...
This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $24,138.00. The contract is for the delivery of unspecified products or services related to BD's Biosciences division, which provides instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...
This is a $68,497.20 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Becton, Dickinson And Company (BD) for the delivery of biological reagents. The contract has a period of performance through July 31, 2025. BD is a global medical technology company that has received numerous federal contract and subcontract awards to provide specialized equipment, consumables, and services in support of biomedical...
This is a $6,532 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD). The contract is not set aside for any particular business category. BD is a global medical technology company that provides instruments, reagents, and services supporting biomedical research and clinical applications, including through flow cytometry, cell imaging, and genomics...